213 related articles for article (PubMed ID: 21279725)
1. Rituximab for refractory cases of childhood nephrotic syndrome.
Kari JA; El-Morshedy SM; El-Desoky S; Alshaya HO; Rahim KA; Edrees BM
Pediatr Nephrol; 2011 May; 26(5):733-7. PubMed ID: 21279725
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
Basu B; Mahapatra TK; Mondal N
Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in steroid-dependent nephrotic syndrome.
El Koumi M
Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for refractory focal segmental glomerulosclerosis.
Nakayama M; Kamei K; Nozu K; Matsuoka K; Nakagawa A; Sako M; Iijima K
Pediatr Nephrol; 2008 Mar; 23(3):481-5. PubMed ID: 17973121
[TBL] [Abstract][Full Text] [Related]
5. Rituximab treatment for adult patients with focal segmental glomerulosclerosis.
Ochi A; Takei T; Nakayama K; Iwasaki C; Kamei D; Tsuruta Y; Shimizu A; Shiohira S; Moriyama T; Itabashi M; Mochizuki T; Uchida K; Tsuchiya K; Hattori M; Nitta K
Intern Med; 2012; 51(7):759-62. PubMed ID: 22466834
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy in nephrotic syndrome: implications for patients' management.
Sinha A; Bagga A
Nat Rev Nephrol; 2013 Mar; 9(3):154-69. PubMed ID: 23338210
[TBL] [Abstract][Full Text] [Related]
7. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
Marasà M; Cravedi P; Ruggiero B; Ruggenenti P
BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25155494
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.
Gulati A; Sinha A; Jordan SC; Hari P; Dinda AK; Sharma S; Srivastava RN; Moudgil A; Bagga A
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2207-12. PubMed ID: 20798255
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in treatment of idiopathic glomerulopathy.
El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
[TBL] [Abstract][Full Text] [Related]
10. Rituximab followed by mycophenolate mofetil in children with IgM nephropathy.
Gu J; Xia Y; Mao J; Fu H; Liu A
Indian Pediatr; 2012 Oct; 49(10):831-3. PubMed ID: 23144102
[TBL] [Abstract][Full Text] [Related]
11. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S; Kamei K; Ogura M; Udagawa T; Fujinaga S; Saito M; Sako M; Iijima K
Pediatr Nephrol; 2013 Feb; 28(2):257-64. PubMed ID: 23052656
[TBL] [Abstract][Full Text] [Related]
12. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
[TBL] [Abstract][Full Text] [Related]
13. Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome.
Kurosu N; Sugiura H; Iwasaki C; Asamiya Y; Kojima C; Moriyama T; Itabashi M; Tsukada M; Takei T; Ogawa T; Yoshida T; Uchida K; Tsuchiya K; Nitta K
Intern Med; 2009; 48(21):1901-4. PubMed ID: 19881243
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
Kronbichler A; König P; Busch M; Wolf G; Mayer G; Rudnicki M
Wien Klin Wochenschr; 2013 Jun; 125(11-12):328-33. PubMed ID: 23624956
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai.
Sun L; Xu H; Shen Q; Cao Q; Rao J; Liu HM; Fang XY; Zhou LJ
World J Pediatr; 2014 Feb; 10(1):59-63. PubMed ID: 24464665
[TBL] [Abstract][Full Text] [Related]
16. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.
van Husen M; Kemper MJ
Pediatr Nephrol; 2011 Jun; 26(6):881-92. PubMed ID: 21229269
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for childhood refractory nephrotic syndrome.
Iijima K
Pediatr Int; 2011 Oct; 53(5):617-621. PubMed ID: 21771179
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
[TBL] [Abstract][Full Text] [Related]
19. Rituximab efficiency in children with steroid-dependent nephrotic syndrome.
Sellier-Leclerc AL; Macher MA; Loirat C; Guérin V; Watier H; Peuchmaur M; Baudouin V; Deschênes G
Pediatr Nephrol; 2010 Jun; 25(6):1109-15. PubMed ID: 20238230
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea.
Ahn YH; Kim SH; Han KH; Choi HJ; Cho H; Lee JW; Shin JI; Cho MH; Lee JH; Park YS; Ha IS; Cheong HI; Kim SY; Lee SJ; Kang HG
Medicine (Baltimore); 2018 Nov; 97(46):e13157. PubMed ID: 30431588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]